Scott Minick
Président chez St. Luke's Hospital (California)
Profil
Scott Minick is the founder of LXR Biotechnology, Inc. He currently holds the position of Chairman at California Pacific Medical Center and St. Luke's Hospital (California).
Additionally, he is the Executive Chairman at Aira Tech Corp.
and serves as a Director at Sorbent Therapeutics, Inc. and Goldilocks Therapeutics, Inc. Previously, he was a Venture Partner at ARCH Venture Partners LLC and Alta Berkeley LLP.
In his former roles, he served as the President, Chief Executive Officer & Director of DNIB Unwind, Inc. from 2011 to 2015.
He was also the President & Chief Executive Officer of Oncotherapeutics, Inc. and Chairman of Xcyte Therapies, Inc. Furthermore, he held the position of President, Chief Operating Officer & Director at SEQUUS Pharmaceuticals, Inc. from 1995 to 1998.
He has also served as a Director at Achaogen, Inc. and held the role of Independent Director at Chiasma, Inc. from 2007 to 2021.
Additionally, he has been an Independent Director at Alzheon, Inc. and a Director at Beth Israel Deaconess Medical Center, Inc., Anagen Therapeutics, Inc., and Limerick BioPharma, Inc. He started his career as a Principal at Baxter Healthcare Corp.
from 1981 to 1992 and also worked as a Principal at Eli Lilly & Co. He holds an MBA from Northwestern University and an undergraduate degree from the University of California San Diego.
Postes actifs de Scott Minick
| Sociétés | Poste | Début |
|---|---|---|
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Directeur/Membre du Conseil | - |
St. Luke's Hospital (California)
 St. Luke's Hospital (California) Medical/Nursing ServicesHealth Services St. Luke's Hospital (California) provides health care services. The hospital's services include outpatient surgery, sub acute care, and respiratory therapy. It was founded in 1871 and is located in San Francisco, CA. | Président | - |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Président | - |
Aira Tech Corp.
 Aira Tech Corp. Finance/Rental/LeasingFinance Aira Tech Corp. develops transformative remote assistive technology and services. It offers visual interpretation services for the blind. The company was founded by Yuja Chang, Watson Yim, Sujeeth Kanuganti, and Suman Kanuganti in 2014 and is headquartered in San Diego, CA. | Président | 25/05/2016 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | - |
Alta Berkeley LLP
 Alta Berkeley LLP Investment ManagersFinance Alta Berkeley LLP (Alta Berkeley) is a venture capital firm in UK. The firm was founded by Bryan Wood in 1982. The firm is headquartered in London, UK. | Private Equity Investor | - |
Anciens postes connus de Scott Minick
| Sociétés | Poste | Fin |
|---|---|---|
| CHIASMA, INC. | Directeur/Membre du Conseil | 05/08/2021 |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | President | 01/01/1998 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/01/1992 |
| ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Scott Minick
| Northwestern University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 20 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
LXR Biotechnology, Inc.
 LXR Biotechnology, Inc. BiotechnologyHealth Technology LXR Biotechnology, Inc. engages in research and development of therapeutics to treat diseases. The private company is based in Richmond, CA. The company was founded by Scott Minick. | Health Technology |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
| Xcyte Therapies, Inc. | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Newton Center, MA. | Health Technology |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
California Pacific Medical Center
California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Commercial Services |
Alta Berkeley LLP
Alta Berkeley LLP Investment ManagersFinance Alta Berkeley LLP (Alta Berkeley) is a venture capital firm in UK. The firm was founded by Bryan Wood in 1982. The firm is headquartered in London, UK. | Finance |
Oncotherapeutics, Inc.
 Oncotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncotherapeutics, Inc. develops and manufactures therapeutic cancer drugs and biomarkers. The firm is a service contract research organization (CRO) with a unique focus on the oncology therapeutic area. Its program encompasses laboratory research, protocol concept, design and development, clinical trial management, monitoring, data management, biostatistics, safety review, clinical and database auditing, medical monitoring, and medical writing. Oncotherapeutics was founded in 1988 and is headquartered in West Hollywood, CA. | Commercial Services |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
Anagen Therapeutics, Inc.
 Anagen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anagen Therapeutics, Inc. develops and manufactures health care products. The company provides different type of medical products for prostate, cardiovascular, neurodegenerative skin and other diseases. The firm is headquartered in Chicago, IL. | Health Technology |
St. Luke's Hospital (California)
St. Luke's Hospital (California) Medical/Nursing ServicesHealth Services St. Luke's Hospital (California) provides health care services. The hospital's services include outpatient surgery, sub acute care, and respiratory therapy. It was founded in 1871 and is located in San Francisco, CA. | Health Services |
Limerick BioPharma, Inc.
 Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Limerick BioPharma is dedicated to the discovery and development of novel small molecule product candidates to address areas of significant unmet medical need. Their intent is to bring forth innovative therapies that have the potential to change treatment paradigms via their enhanced safety and / or efficacy profiles. Limerick is developing novel products that can enhance the safety of existing therapeutic agents or function as innovative stand-alone therapies. Their lead programs are in the areas of metabolic diseases and solid organ transplantation. In metabolic diseases, their programs are in clinical development for treatment of diabetes and dyslipidemia. For transplant indications, their programs are in clinical development as adjunctive therapy to treat metabolic dysregulation induced by leading immunosuppressants. Beyond these first-generation programs, Limerick has developed a proprietary and cutting-edge discovery platform that can be leveraged for other high-need, high-value areas. They intend to maximize the value of their product candidates and discovery platform through independent development, licensing and other partnership opportunities. | Health Technology |
Aira Tech Corp.
Aira Tech Corp. Finance/Rental/LeasingFinance Aira Tech Corp. develops transformative remote assistive technology and services. It offers visual interpretation services for the blind. The company was founded by Yuja Chang, Watson Yim, Sujeeth Kanuganti, and Suman Kanuganti in 2014 and is headquartered in San Diego, CA. | Finance |
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Finance |
Goldilocks Therapeutics, Inc.
 Goldilocks Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Goldilocks Therapeutics, Inc. engages in the development of drug delivery technology for kidney tubules. It offers treatment for acute kidney injury (AKI), polycystic kidney disease (PKD), and other under-treated kidney conditions by leveraging the Company’s proprietary mesoscale nanoparticles (MNPs). The company was founded by Arthur J. Klausner, Daniel A. Heller, and Edgar A. Jaimes in 2018 and is headquartered in Bedford, NY. | Commercial Services |
